Similarly, Fahlbusch et al. demonstrated that circulating levels of IGFBP2 are lower in patients with NAFLD and NASH, and are restored after weight loss following bariatric surgery along with reductions in hepatic fat content [92]. Here, IGFBP2 is linked to metabolic dysfunction-associated steatotic liver disease.